Business Segments · Gain (Loss) on Investments

Business Segments — Gain (Loss) on Investments

Roivant Sciences Business Segments — Gain (Loss) on Investments decreased by 83.2% to $21.59M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 201.3%, from -$21.31M to $21.59M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityVolatile
First reportedQ2 2023
Last reportedQ4 2025

How to read this metric

Positive values indicate successful investment performance, while negative values indicate market volatility or poor asset selection.

Detailed definition

This reflects the change in the market value of financial investments held by the segment, including realized and unreal...

Peer comparison

Common for companies with significant cash reserves or strategic venture portfolios.

Metric ID: roiv_segment_reportable_segment_gain_loss_on_investments

Historical Data

10 periods
 Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q3 '25Q4 '25
Value-$11.99M-$11.99M-$11.99M-$11.99M$15.23M$48.38M-$21.31M$12.90M$128.50M$21.59M
QoQ Change+0.0%+0.0%+0.0%+227.0%+217.7%-144.1%+160.5%+896.2%-83.2%
YoY Change+227.0%+503.4%-77.7%+207.6%+165.6%+201.3%
Range-$21.31M$128.50M
CAGR+29.9%
Avg YoY Growth+204.5%
Median YoY Growth+204.4%

Frequently Asked Questions

What is Roivant Sciences's business segments — gain (loss) on investments?
Roivant Sciences (ROIV) reported business segments — gain (loss) on investments of $21.59M in Q4 2025.
How has Roivant Sciences's business segments — gain (loss) on investments changed year-over-year?
Roivant Sciences's business segments — gain (loss) on investments increased by 201.3% year-over-year, from -$21.31M to $21.59M.
What does business segments — gain (loss) on investments mean?
Profit or loss from the segment's investment holdings.